207 related articles for article (PubMed ID: 12107601)
1. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma.
Shioya T; Satake M; Sano M; Kagaya M; Watanabe A; Sato K; Ito T; Ito N; Sasaki M; Miura M
Eur J Clin Pharmacol; 2002 Jun; 58(3):171-6. PubMed ID: 12107601
[TBL] [Abstract][Full Text] [Related]
2. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
Yokomura K; Suda T; Matsuda H; Hashizume H; Asada K; Suzuki K; Chida K
J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
[TBL] [Abstract][Full Text] [Related]
3. Effect of an orally active Th2 cytokine inhibitor, suplatast on "atopic cough" tosilate.
Ishiura Y; Fujimura M; Yamamoto H; Nobata K; Ishiguro T; Ogawa H; Myou S
Arzneimittelforschung; 2008; 58(6):297-302. PubMed ID: 18677972
[TBL] [Abstract][Full Text] [Related]
4. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
Yoshihara S; Fukuda H; Arisaka O
Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
[TBL] [Abstract][Full Text] [Related]
6. Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma.
Sano Y; Suzuki N; Yamada H; To Y; Ogawa C; Ohta K; Adachi M
J Allergy Clin Immunol; 2003 May; 111(5):958-66. PubMed ID: 12743558
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of suplatast tosilate on eosinophil migration].
Kobayashi Y; Nagata M; Yamamoto H; Sakamoto Y
Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827
[TBL] [Abstract][Full Text] [Related]
8. Effects of suplatast tosilate on airway inflammation and airway hyperresponsiveness.
Horiguchi T; Tachikawa S; Handa M; Hanazono K; Kondo R; Ishibashi A; Banno K
J Asthma; 2001 Jun; 38(4):331-6. PubMed ID: 11456386
[TBL] [Abstract][Full Text] [Related]
9. Add-on effects of suplatast tosilate in bronchial asthma patients treated with inhaled corticosteroids.
Sano T; Nakamura Y; Yanagawa H; Bando H; Nii A; Yoshida S; Sone S;
Lung; 2003; 181(4):227-35. PubMed ID: 14692563
[TBL] [Abstract][Full Text] [Related]
10. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
Kimata H
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
[TBL] [Abstract][Full Text] [Related]
11. Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients.
Yoshida M; Aizawa H; Inoue H; Matsumoto K; Koto H; Komori M; Fukuyama S; Okamoto M; Hara N
J Asthma; 2002 Sep; 39(6):545-52. PubMed ID: 12375715
[TBL] [Abstract][Full Text] [Related]
12. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice.
Furonaka M; Hattori N; Tanimoto T; Senoo T; Ishikawa N; Fujitaka K; Haruta Y; Yokoyama A; Kohno N
J Pharmacol Exp Ther; 2009 Jan; 328(1):55-61. PubMed ID: 18832650
[TBL] [Abstract][Full Text] [Related]
13. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group.
Tamaoki J; Kondo M; Sakai N; Aoshiba K; Tagaya E; Nakata J; Isono K; Nagai A
Lancet; 2000 Jul; 356(9226):273-8. PubMed ID: 11071181
[TBL] [Abstract][Full Text] [Related]
14. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
15. Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study.
Yoshihara S; Ono M; Yamada Y; Fukuda H; Abe T; Arisaka O
Pediatr Allergy Immunol; 2009 Aug; 20(5):486-92. PubMed ID: 19210644
[TBL] [Abstract][Full Text] [Related]
16. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of airway inflammatory cells and mediators in eosinophilic bronchitis patients].
Luo W; Lai KF; Chen RC; Liu CL; Zeng YX; Zhong SQ; Li DR; Wu H; He MZ; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Sep; 28(9):626-9. PubMed ID: 16207433
[TBL] [Abstract][Full Text] [Related]
18. The effects of suplatast tosilate treatment and prophylaxis on lung histopathology in a mouse model of chronic asthma.
Tuncel T; Karaman M; Ayyildiz ZA; Uysal P; Kiray M; Bagriyanik AH; Yilmaz O; Karaman O; Uzuner N
J Investig Med; 2014 Jan; 62(1):56-61. PubMed ID: 24113733
[TBL] [Abstract][Full Text] [Related]
19. Angiolymphoid hyperplasia with eosinophilia on the leg successfully treated with T-helper cell 2 cytokine inhibitor suplatast tosilate.
Bito T; Kabashima R; Sugita K; Tokura Y
J Dermatol; 2011 Mar; 38(3):300-2. PubMed ID: 21342240
[No Abstract] [Full Text] [Related]
20. Anti-inflammatory effect of suplatast tosilate on mild asthma.
Sano Y; Miyamoto T; Makino S
Chest; 1997 Sep; 112(3):862-3. PubMed ID: 9315837
[No Abstract] [Full Text] [Related]
[Next] [New Search]